2026
- Protocol for a phase 3, randomized, double-blind clinical trial evaluating the safety and immunogenicity of the MVA-BN® vaccine against mpox in children aged 4 to less than 24 months in the Democratic Republic of the Congo: Data to guide future paediatric vaccination strategies
Vaccine
2026-08 | Journal article
DOI: 10.1016/j.vaccine.2026.128890
Contributors: Solange Milolo Tshilumba; Paulina Morales Ruiz; Trésor Zola Matuvanga; Gwen Lemey; Primo Kimbulu; Mahmoud Abu Azoum; Maha Salloum; Gustave Kasereka; Felly Mitashi; Freddy Bikioli et al.
- PregInPoxVac maternal protocol: a phase 3 trial evaluating maternal immunogenicity and safety of the MVA-BN vaccine in the Democratic Republic of the Congo
BMJ Open
2026-07 | Journal article
DOI: 10.1136/bmjopen-2025-115710
Contributors: Paulina Morales Ruiz; Solange Milolo Tshilumba; Kirsten Maertens; Vivi Maketa; Primo Kimbulu; Felly Mitashi; Mahmoud Abu Azoum; Gustave Kasereka; Aurélie Bisumba; Maha Salloum et al.